Biogen Historical Income Statement
BIIB Stock | USD 201.99 8.81 4.56% |
Historical analysis of Biogen income statement accounts such as Interest Expense of 259.2 M, Selling General Administrative of 2.6 B or Total Revenue of 10.3 B can show how well Biogen Inc performed in making a profits. Evaluating Biogen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Biogen's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Biogen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biogen Inc is a good buy for the upcoming year.
Biogen |
About Biogen Income Statement Analysis
Biogen Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Biogen shareholders. The income statement also shows Biogen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Biogen Income Statement Chart
Biogen Inc Income Statement is one of the three primary financial statements used for reporting Biogen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biogen Inc revenue and expense. Biogen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Biogen's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 2.6 B, whereas Depreciation And Amortization is forecasted to decline to about 256.8 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Biogen Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Biogen Inc minus its cost of goods sold. It is profit before Biogen operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Biogen Inc. It is also known as Biogen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Biogen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At present, Biogen's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 2.6 B, whereas Depreciation And Amortization is forecasted to decline to about 256.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 8.9B | 7.9B | 7.3B | 3.9B | Total Revenue | 11.0B | 10.2B | 9.8B | 10.3B |
Biogen income statement Correlations
Click cells to compare fundamentals
Biogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biogen income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 476.1M | 257.2M | 815.9M | 365.9M | 494.8M | 256.8M | |
Interest Expense | 187.4M | 222.5M | 253.6M | 246.6M | 246.9M | 259.2M | |
Selling General Administrative | 2.3B | 2.4B | 2.6B | 2.3B | 2.5B | 2.6B | |
Total Revenue | 14.4B | 13.4B | 11.0B | 10.2B | 9.8B | 10.3B | |
Gross Profit | 12.4B | 11.6B | 8.9B | 7.9B | 7.3B | 3.9B | |
Other Operating Expenses | 7.3B | 9.0B | 8.2B | 7.3B | 8.0B | 8.4B | |
Operating Income | 7.0B | 4.6B | 2.8B | 2.3B | 1.3B | 1.6B | |
Ebit | 7.0B | 4.6B | 2.8B | 2.3B | 2.1B | 1.7B | |
Ebitda | 7.5B | 4.8B | 3.7B | 2.7B | 2.6B | 1.9B | |
Cost Of Revenue | 2.0B | 1.8B | 2.1B | 2.3B | 2.5B | 2.7B | |
Total Operating Expenses | 5.4B | 7.2B | 6.1B | 5.0B | 5.5B | 5.7B | |
Income Before Tax | 7.1B | 5.0B | 1.7B | 3.6B | 1.3B | 1.6B | |
Total Other Income Expense Net | 83.3M | 497.4M | (1.1B) | 1.3B | (563.9M) | (535.7M) | |
Net Income | 5.9B | 4.0B | 1.6B | 3.0B | 1.2B | 1.2B | |
Income Tax Expense | 1.2B | 992.3M | 52.5M | 632.8M | 135.3M | 128.5M | |
Research Development | 2.3B | 4.0B | 2.5B | 2.2B | 2.5B | 1.4B | |
Net Income Applicable To Common Shares | 5.9B | 4.0B | 1.6B | 3.0B | 3.5B | 2.0B | |
Minority Interest | (4.1M) | 59.9M | 171.5M | 85.3M | (400K) | (380K) | |
Net Income From Continuing Ops | 6.0B | 4.1B | 1.7B | 3.0B | 1.2B | 1.1B | |
Non Operating Income Net Other | 3.9M | 502.7M | (1.1B) | 614.5M | 706.7M | 742.0M | |
Non Recurring | 1.5M | 75M | 18M | 131.1M | 118.0M | 99.1M | |
Tax Provision | 1.2B | 992.3M | 52.5M | 632.8M | 135.3M | 128.5M | |
Interest Income | 120M | 42M | 11M | 89.3M | 276.5M | 290.3M | |
Net Interest Income | (67.4M) | (180.5M) | (242.6M) | (157.3M) | 29.6M | 31.1M | |
Reconciled Depreciation | 680.6M | 457.2M | 487.7M | 365.9M | 494.8M | 523.9M |
Biogen Investors Sentiment
The influence of Biogen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biogen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biogen.
Biogen Implied Volatility | 65.17 |
Biogen's implied volatility exposes the market's sentiment of Biogen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biogen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biogen stock will not fluctuate a lot when Biogen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biogen's short interest history, or implied volatility extrapolated from Biogen options trading.
Pair Trading with Biogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.Moving against Biogen Stock
0.76 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
0.74 | NRSNW | NeuroSense Therapeutics | PairCorr |
0.71 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
0.68 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
0.67 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 7.98 | Revenue Per Share 67.972 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0458 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.